ArticleJournal of neurological surgery. Part B, Skull base2026
Patency of the Cavernous Sinus After Medial Wall Resection: An Observational Study.
Article in Journal of neurological surgery. Part B, Skull base, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The cavernous sinus medial wall (CSMW) is a critical structure that can be resected in cavernous sinus (CS)-invading tumors. Intraoperative venous bleeding is inevitable upon entering the CS and necessitates hemostatic agents use to cease its flow. There is no literature on the fate of CS patency after such hemostasis. This study aims to address that gap. Methods: An observational study was conducted between 2018 and 2025, including patients undergoing endoscopic endonasal approach (EEA) with CSMW or transcavernous resection for CS-invading tumors. Pre- and postoperative magnetic resonance imaging (MRI) images were collected and analyzed for CS patency. Postoperative imaging was grouped into three intervals: 0 to 3, 3 to 12, and >12 months. Demographic data were analyzed to identify predictors of CS non-patency. Results: Of the 186 patients included, postoperative CS patency was achieved in 87.1% after 3.72 months. Univariate analysis demonstrated that preoperative CS non-patency ( Conclusion: This is the first study to report that postoperative CS patency is preserved in most cases after EEA requiring CSMW. A strong predictor of postoperative CS non-patency was identified as preoperative CS non-patency. Further studies are warranted to assess if CS non-patency has significant clinical correlations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.